Updates are available Correction dated 2024-07-02

Article History

Received: 12 October 2023

Accepted: 7 March 2024

First Online: 25 April 2024

Change Date: 2 July 2024

Change Type: Correction

Change Details: A Correction to this paper has been published:

Change Details: https://doi.org/10.1007/s12519-024-00826-x

Declarations

:

: NLCE, BJM, LCR, HMA, BG, AAMI, AMW, BCLH, OKJ, HS and TLSWJ have nothing to declare. M-ZAH is the PI of a public private consortium [P4O2 (Precision Medicine for More Oxygen)] sponsored by Health Holland involving many private partners that contribute in cash and/or in kind (AbbVie. Boehringer Ingelheim, Breathomix, Clear, Fluidda, Ortec Logiqcare, Olive, Philips, Quantib-U, Smartfish, Clear, SODAQ, Thirona, Roche, TopMD, Novartis, RespiQ). She received unrestricted research grants from GSK and Boehringer Ingelheim and received the Vertex innovation award grant, and had honoraria paid to institution by GSK, Boehringer Ingelheim and Astra Zeneca. MZAH is also the chair of DSMB of a study on BPD in neonates and the president of FIGON (Federation Innovative drug research in the Netherlands). GJB has received a grant from Danone Research and has a patent planned for amino acid composition of infant formulas. He is a member of the national health council (unpaid) and the director of the national Human Milk Bank (unpaid).

: The medical ethics committee of the Amsterdam UMC, location AMC, approved the study (METc 2021_126). Informed consent to participate in the study has been obtained from all participants (or their parent or legal guardian in the case of children under 16).